Avita Medical | Marktkapitalisierung



Market Capitalization Veränderung Datum
Celltrion KRW 33.15T 4.76T 2025-05
Clinuvel Pharmaceuticals AUD 603.73M 166.36M 2024-12
Cochlear AUD 18.97B 2.79B 2024-12
CSL AUD 136.34B 6.32B 2024-12
Cspc Pharmaceutical HKD 55.63B 15.43B 2024-12
Dianthus Therapeutics USD 645M 159M 2024-12
Divis Laboratories Ltd 1.72T 190.9B 2025-05
Knight Therapeutics CAD 599.03M 24.75M 2024-09
Laboratorios Farma EUR 3.22B 1.26B 2024-12
Mayne Pharma AUD 403.79M 3.09M 2024-12
Neuren Pharmaceuticals AUD 1.6B 1.12B 2024-12
Organigram Holdings CAD 239.53M 15.62M 2024-12
Paradigm Biopharmaceuticals AUD 145.99M 56.79M 2024-12
Pharma Mar EUR 1.35B 128.91M 2025-05
Qiagen NV EUR 8.24B 219.42M 2025-05
Sartorius EUR 8.19B 6.16B 2025-05
Sino Biopharmaceutical HKD 60.13B 9.96B 2024-12
Telix Pharmaceuticals AUD 8.24B 2B 2024-12
Zz Pientze Pharmaceu 125.22B 3.3B 2025-05



Avita Medical Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.